Elisa Salvan
Impact in
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Papers in
- Rheumatology 10
- Systemic Lupus Erythematosus Research 10
-
- Platelet Disorders and Treatments 3
- Blood Coagulation and Thrombosis Mechanisms 1
- Co-authors
- Amelia Ruffatti (11 shared papers)Marta Tonello (7 shared papers)Vittorio Pengo (3 shared papers)Teresa Del Ross (4 shared papers)Elisa Bison (1 shared paper)Paola Caramaschi (2 shared papers)Maria Tiziana Bertero (2 shared papers)Anǵela Tincani (2 shared papers)
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)Thrombosis Research (1 paper)Lupus (1 paper)Archives of Gynecology and Obstetrics (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- ItalySwedenUnited States
In The Last Decade
Elisa Salvan
11 papers receiving 459 citations
Peers
Comparison fields: 5 of 30
- Rheumatology 421
- Hematology 194
- Nephrology 70
- Hepatology 24
- Radiology, Nuclear Medicine and Imaging 59
Countries citing papers authored by Elisa Salvan
This map shows the geographic impact of Elisa Salvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Salvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Salvan more than expected).
Fields of papers citing papers by Elisa Salvan
This network shows the impact of papers produced by Elisa Salvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Salvan. The network helps show where Elisa Salvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisa Salvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 143 | |
| 2 | 2008 | 107 | |
| 3 | 2014 | 79 | |
| 4 | 2019 | 32 | |
| 5 | 2015 | 28 | |
| 6 | 2012 | 25 | |
| 7 | 2014 | 25 | |
| 8 | 2012 | 13 | |
| 9 | 2020 | 10 | |
| 10 | 2011 | 3 | |
| 11 | Significato clinico degli anticorpi anti acido lisobisfosfatidico nei pazienti con sindrome da antifosfolipidi primaria Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome | 2010 | 1 |
About Elisa Salvan
Elisa Salvan is a scholar working on Rheumatology, Hematology, Genetics, Molecular Biology and Nephrology, having authored 11 papers that have together received 466 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (10 papers), Platelet Disorders and Treatments (3 papers), Diabetes and associated disorders (3 papers), Renal Diseases and Glomerulopathies (1 paper), Blood Coagulation and Thrombosis Mechanisms (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and Sphingolipid Metabolism and Signaling (1 paper). The work is most often cited by research in Rheumatology (421 citations), Hematology (194 citations), Nephrology (70 citations), Hepatology (24 citations) and Radiology, Nuclear Medicine and Imaging (59 citations). Elisa Salvan has collaborated with scholars based in Italy, Sweden and United States. Frequent co-authors include Amelia Ruffatti, Marta Tonello, Vittorio Pengo, Teresa Del Ross, Elisa Bison, Paola Caramaschi, Maria Tiziana Bertero, Anǵela Tincani, Antonio Brucato and Pier Luigi Meroni. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Thrombosis Research, Lupus, Archives of Gynecology and Obstetrics and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.